Biolase filings

Author: okpb

August undefined, 2024

WebSEC Filings. Insider Monkey. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2024 Earnings Call Transcript. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2024 Earnings Call Transcript March 28, 2024 Operator: Greetings. Welcome ... WebFeb 1, 2024 · BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical …

BIOL Biolase Inc. SEC Filings MarketWatch

WebJun 28, 2011 · Reference is hereby made to that certain License Agreement, which is in effect having an effective date of January 1, 2009 (which superseded that certain License Agreement, with an effective date of January 24, 2007), by and between Biolase Technology, Inc. (“BIOLASE”) and The Procter & Gamble Company (“P&G”) (the … WebManage internal and external financial reporting for Biolase, Inc., a biomedical device company that develops, manufactures, and markets … mouth angielski

Biolase, Inc. Common Stock (BIOL) SEC Filings Nasdaq

WebJun 12, 2024 · If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e ... WebMar 28, 2024 · BIOLASE, INC General Corporate Statement (Form8) Accepted: March 28, 2024 at 8:06 PM UTC. Form Type: 8-K. Accession Number: 0000950170-23-010279. WebSep 23, 2013 · EX-10.1 3 exhibit2.htm EX-10.1 EX-10.1 . SUBSCRIPTON AGREEMENT. This agreement is dated September 23, 2013 between the undersigned (“Buyer”) and Biolase, Inc., a Delaware corporation having a principal place of business at 4 Cromwell, Irvine, California 92618 (“Seller”), whereby the parties agree as follows: The Buyer shall … mouth anglais

Google My Business, Local SEO Guide Is Not In Kansas - MediaPost

Form SC 13D/A BIOLASE, INC Filed by: FEINBERG LARRY N

WebApr 10, 2024 · All Filings. Form. Description. Date. Format. SC 13G. Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions. Mar 9, 2024. Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by … WebBIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally … mouth and tongue sores treatmentWebDec 12, 2024 · Table of Contents As filed with the Securities and Exchange Commission on December 12, 2024 Registration No. 333-268528 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. heart wheelchair

"WebApr 14, 2024 · Recently Concluded Data & Programmatic Insider Summit March 22 - 25, 2024, Scottsdale Digital OOH Insider Summit February 19 - 22, 2024, La Jolla " - Biolase filings

Biolase filings

BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat

Did you know?

WebAug 11, 2024 · Biolase, Inc (BIOL) SEC Filing 8-K Material Event for the period ending Thursday, August 11, 2024 WebMar-17-21 08:30AM. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2024 Results on March 25, 2024. PR Newswire +9.03%. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.

WebApr 11, 2024 · A high-level overview of BIOLASE, Inc. (BIOL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebMar 17, 2024 · Lake Forest, Calif., March 17, 2024 – BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter …

WebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … WebBiolase Inc. SEC filings breakout by MarketWatch. View the BIOL U.S. Securities and Exchange Commission reporting information.

WebBIOLASE INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. BIOLASE INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

WebApr 12, 2024 · About BIOLASE (NASDAQ:BIOL) Stock BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It … mouth animal crossingWebJun 23, 2011 · BIOLASE Technology, Inc. 4 Cromwell. Irvine, CA 92618. Dear Mr. Pignatelli: Reference is made to that certain letter agreement (“ Letter Agreement ”), dated June 22, 2011, by and between BIOLASE Technology (the “ Company ”) and Rodman & Renshaw, LLC (“ Rodman ”) pursuant to which Rodman shall serve as the exclusive lead … heart wheel rimsWebBIOLASE Inc (US:BIOL) has 4 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,061 shares. Largest … mouth angleWebBiolase hereby agrees to repurchase from Schein **** 182 MDs currently in Schein’s possession, free and clear of all liens and encumbrances. ... All documents shall be duly executed by authorized signatories and, when customary or necessary for filing or recordation, properly acknowledged. a. Biolase. Biolase shall ****, and less ****. heart wheels carWebBiolase Inc. Watch list Create BIOL Alert Closed Last Updated: Dec 28, 2024 4:00 p.m. EST Delayed quote $ 0.6231 -0.0069 -1.10% Previous Close $0.6300 Advanced … mouth anginaWebSep 30, 2024 · SEC filings and transcripts for Biolase Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements Biolase Inc – Filings and … heart what does it meanWebMay 24, 2024 · Hello, I Really need some help. Posted about my SAB listing a few weeks ago about not showing up in search only when you entered the exact name. I pretty … mouth angular cheilitis